Streetbeat News

Regulatory

GNFT

IPSEY

GENFIT's Iqirvo, the first-ever drug developed in-house by the company, has received FDA approval. GENFIT is set to receive a €48.7 million milestone payment from Ipsen upon the first commercial sale in the U.S., along with tiered double-digit royalties up to 20%.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 9:26 pm

ADM

ADM Animal Nutrition has expanded its recalls announced in March and April to include additional products due to elevated levels of magnesium, sodium, calcium, chloride, and/or phosphorus. No illnesses have been reported to date.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 9:05 pm

BITF

Bitfarms announced that it has been notified by the Toronto Stock Exchange (TSX) regarding the deferral of consideration of its shareholder rights plan.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 9:03 pm

GNFT

IPSEY

Ipsen announced that Iqirvo has secured FDA accelerated approval as the first-in-class PPAR treatment for primary biliary cholangitis. Iqirvo, an oral, once-daily PPAR agonist, was in-licensed from GENFIT in 2021.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 8:59 pm

GNFT

Trading for GNFT was halted at 4:42:03 p.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 8:42 pm

CURLF

Curaleaf International Holdings (OTC:CURLF) is expanding its cannabis operations into Australia, New Zealand, and Israel. The Australian market is particularly promising due to its size and favorable regulatory environment. Curaleaf's acquisition of Northern Green Canada (NGC) aids its Australian operations. New Zealand and Israel also offer growth opportunities despite their smaller market sizes. Curaleaf leverages its cultivation facilities in Portugal and Canada to meet regulatory standards and supply these markets.

Portfolio Pulse from Nicolás Jose Rodriguez

June 10, 2024 | 8:27 pm

EIS

SPY

Hamas has welcomed the UN Security Council resolution calling for a ceasefire in Gaza and expressed readiness to cooperate with mediators for its implementation.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 8:00 pm

RNAZ

TransCode Therapeutics shares are trading higher after the company announced that it regained compliance with the Nasdaq's continued listing requirements.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 7:44 pm

EIS

SPY

The UN Security Council has adopted a US-drafted resolution supporting President Biden's ceasefire proposal between Israel and Hamas, with Russia abstaining from the vote.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 7:44 pm

TSLA

The California Department of Motor Vehicles (DMV) is proceeding with its case against Tesla, accusing the company of false advertising related to its Autopilot feature. The DMV claims that Tesla misled consumers about the capabilities of its Autopilot system.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 7:23 pm